EA200200518A1 - METHOD AND COMPOSITION FOR THE TREATMENT OF PULMONARY DISEASES - Google Patents

METHOD AND COMPOSITION FOR THE TREATMENT OF PULMONARY DISEASES

Info

Publication number
EA200200518A1
EA200200518A1 EA200200518A EA200200518A EA200200518A1 EA 200200518 A1 EA200200518 A1 EA 200200518A1 EA 200200518 A EA200200518 A EA 200200518A EA 200200518 A EA200200518 A EA 200200518A EA 200200518 A1 EA200200518 A1 EA 200200518A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pulmonary diseases
treatment
composition
phosphodiesterase
asthma
Prior art date
Application number
EA200200518A
Other languages
Russian (ru)
Inventor
Петер Н. Гудфеллоу
Ричард Нимэн
Теодор Дж. Торфи
Original Assignee
Смитклайн Бичам Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичам Корпорейшн filed Critical Смитклайн Бичам Корпорейшн
Publication of EA200200518A1 publication Critical patent/EA200200518A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Настоящее изобретение относится к способам лечения заболеваний легких, таких как хроническая обструктивная болезнь легких или астма, путем введения ингибитора фосфодиэстеразы 4 в комбинации с противовоспалительным кортикостероидом.Отчет о международном поиске был опубликован 2001.12.06.The present invention relates to methods for treating pulmonary diseases, such as chronic obstructive pulmonary disease or asthma, by administering a phosphodiesterase 4 inhibitor in combination with an anti-inflammatory corticosteroid. The international search report was published 2001.12.06.

EA200200518A 1999-11-02 2000-11-01 METHOD AND COMPOSITION FOR THE TREATMENT OF PULMONARY DISEASES EA200200518A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02
PCT/US2000/030113 WO2001032127A2 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Publications (1)

Publication Number Publication Date
EA200200518A1 true EA200200518A1 (en) 2002-10-31

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200518A EA200200518A1 (en) 1999-11-02 2000-11-01 METHOD AND COMPOSITION FOR THE TREATMENT OF PULMONARY DISEASES

Country Status (29)

Country Link
EP (1) EP1225866A4 (en)
JP (1) JP2003513028A (en)
KR (1) KR20020057988A (en)
CN (1) CN1387404A (en)
AP (1) AP2002002496A0 (en)
AR (1) AR029189A1 (en)
AU (1) AU1357501A (en)
BG (1) BG106748A (en)
BR (1) BR0015270A (en)
CA (1) CA2388333A1 (en)
CO (1) CO5261512A1 (en)
CZ (1) CZ20021512A3 (en)
DZ (1) DZ3225A1 (en)
EA (1) EA200200518A1 (en)
EC (1) ECSP003747A (en)
HK (1) HK1049107A1 (en)
HU (1) HUP0203152A3 (en)
IL (1) IL149367A0 (en)
MA (1) MA26841A1 (en)
MX (1) MXPA02004350A (en)
NO (1) NO20022057L (en)
OA (1) OA12076A (en)
PE (1) PE20011005A1 (en)
PL (1) PL355261A1 (en)
SK (1) SK7592002A3 (en)
TR (1) TR200201211T2 (en)
TW (1) TWI242431B (en)
WO (1) WO2001032127A2 (en)
ZA (1) ZA200203435B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1429807T1 (en) * 2001-09-19 2007-08-31 Nycomed Gmbh Combination of a nsaid and a pde-4 inhibitor
CZ2004516A3 (en) * 2001-10-31 2004-08-18 Merckápatentágmbh Type 4 phosphodiesterase inhibitor, combinations thereof with other drugs and its use
UA82323C2 (en) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Novel combination of a glucocorticoid and pde-inhibitor for the treatment of respiratory diseases, allergic diseases, asthma and chronic obstructive pulmonary diseases
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
WO2004087149A1 (en) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co. Ltd. Medicinal composition
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20070287689A1 (en) * 2004-10-13 2007-12-13 Kyowa Hakko Kogyo Co., Ltd. Therapeutic And/Or Preventive Agents For Chronic Skin Diseases
US20090054382A1 (en) * 2005-10-19 2009-02-26 Abhijit Ray Compositions of phosphodiesterase type iv inhibitors
CN104338219B (en) 2010-01-05 2017-10-24 微剂量治疗技术公司 inhalation device and method
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1466598A3 (en) * 1993-06-18 2007-06-27 Smithkline Beecham Corporation PDE-IV inhibitors
DE4332041C2 (en) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Use of pentoxifylline in certain lung diseases
PE44995A1 (en) * 1994-01-27 1995-12-18 Schering Corp MOMETASONE FUROATE FOR THE TREATMENT OF LUNG DISEASES AND RESPIRATORY TRACT
SE9801368D0 (en) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
CZ20021512A3 (en) 2003-04-16
PE20011005A1 (en) 2001-09-28
WO2001032127A3 (en) 2001-12-06
NO20022057D0 (en) 2002-04-30
BG106748A (en) 2003-02-28
ECSP003747A (en) 2002-05-23
HUP0203152A3 (en) 2004-06-28
TR200201211T2 (en) 2002-08-21
PL355261A1 (en) 2004-04-05
IL149367A0 (en) 2002-11-10
CO5261512A1 (en) 2003-03-31
CA2388333A1 (en) 2001-05-10
AR029189A1 (en) 2003-06-18
BR0015270A (en) 2002-06-18
SK7592002A3 (en) 2002-11-06
OA12076A (en) 2006-05-04
WO2001032127A2 (en) 2001-05-10
AP2002002496A0 (en) 2002-06-30
MXPA02004350A (en) 2002-11-07
ZA200203435B (en) 2003-06-25
KR20020057988A (en) 2002-07-12
HUP0203152A2 (en) 2003-01-28
HK1049107A1 (en) 2003-05-02
JP2003513028A (en) 2003-04-08
CN1387404A (en) 2002-12-25
EP1225866A2 (en) 2002-07-31
NO20022057L (en) 2002-06-27
DZ3225A1 (en) 2001-05-10
AU1357501A (en) 2001-05-14
EP1225866A4 (en) 2004-04-21
MA26841A1 (en) 2004-12-20
TWI242431B (en) 2005-11-01

Similar Documents

Publication Publication Date Title
EA200300293A1 (en) ANTI-INFLAMMATORY CONDENSED Pyrrolocarbazoles
EP1007556A4 (en) Troponin subunits and fragments useful as angiogenesis inhibitors
EA200400648A1 (en) N, N'-SUBSTITUTED DERIVATIVES 1,3-DIAMINO-2-HYDROXYPROPANE
BR0310106A (en) Compound, process for producing a compound, pharmaceutical composition, use of the compound and method for treating a subject suffering from a pathological condition or disease
DE60327999D1 (en) AZOLYLAMINOAZINES AS INHIBITORS OF PROTEIN KINASES
WO2003000241A3 (en) Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents, for the treatment of inflammatory and/or obstructive respiratory tract diseases
NO20052595L (en) Compositions useful as inhibitors of ROCK and other protein kinases.
ATE178044T1 (en) ARGININE KETOAMIDE ENZYME INHIBITORS
PE20001032A1 (en) COMPOSITIONS AND METHODS TO TREAT PULMONARY DISEASES
NO20050851L (en) Caspase Inhibitors and Uses thereof
BR9406979A (en) Compound, pharmaceutical composition for treating an inflammatory disease susceptible to treatment with a non-steroidal anti-inflammatory agent processes for treating an inflammatory disease and for preparing a pharmaceutically acceptable salt compound use of a non-steroidal anti-inflammatory pharmaceutical composition compound
WO2002004449A3 (en) Methods for treatment of conditions affected by activity of multidrug transporters
WO2003011274A3 (en) Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma
EP1251126A3 (en) Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
EA199900421A1 (en) PETROPHYDRIDINE AS BRONCHIAL THERAPEUTIC TOOLS
EA200101214A1 (en) SUBSTITUTED POLYCYCLIC ARYL- AND HETEROYARYL-PYRIMIDINONES USED AS ANTICOAGULANTS
BR0316458A (en) Compound, pharmaceutical composition, method of treating or preventing disease, method for enhancing cognition in a healthy patient, and use of a compound
EA200500244A1 (en) TETRAPROPILAMMONIA TETRATIOMOLYBDAT AND RELATED COMPOUNDS FOR ANTIANGIOGENIC THERAPY
DE60140871D1 (en) ARYLMETHYLAMINE DERIVATIVES FOR USE AS INHIBITORS OF TRYPTASE
ATE457177T1 (en) COMBINATION THERAPY FOR THE TREATMENT OF RESPIRATORY DISEASES USING ANTIBODIES AND ANTI-INFLAMMATORY ACTIVES
EA200200518A1 (en) METHOD AND COMPOSITION FOR THE TREATMENT OF PULMONARY DISEASES
MXPA03011702A (en) Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases.
EA200100930A1 (en) METHOD OF TREATMENT COPD
EA200001140A1 (en) COMPOUNDS INHIBITORS sPLA2 FOR THE TREATMENT OF DISEASE
FI965097A (en) Substituted alkyldiamine derivatives and their use as tachykinin antagonists